Brief: India's Suven Life Sciences March Qtr Profit Rises
May 15 (Reuters) - Suven Life Sciences Ltd SUVP.NS :
* MARCH QUARTER NET PROFIT 625.1 MILLION RUPEES VERSUS
PROFIT
400.7 MILLION RUPEES YEAR AGO
* MARCH QUARTER TOTAL REVENUE FROM OPERATIONS 2.14 BILLION
RUPEES
VERSUS 1.80 BILLION RUPEES YEAR AGO
Source text - https://bit.ly/2k1BfUN
Further company coverage: SUVP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences Says First Patient Randomized In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees